Neighbors Counseling
← The Journal

Spravato for Treatment-Resistant Depression in Allen, TX: Is Esketamine Right for You?

Explore Spravato treatment in Allen, TX for treatment-resistant depression. Learn how esketamine works, who qualifies, and how our integrated care team can help.

9 min read

If you've been living with depression for months or years, trying medication after medication without real relief, you already know how exhausting that journey can feel. You're not alone, and you're not out of options. Spravato treatment in Allen, TX is now available for adults who haven't found lasting relief from traditional antidepressants, and it may be the breakthrough you've been waiting for.

What Is Spravato (Esketamine)?

Spravato is the brand name for esketamine, a nasal spray that works differently from traditional antidepressants. While most antidepressants target serotonin or norepinephrine, University of Texas Health Science Center at Houston explains that Spravato is an FDA-approved intranasal antidepressant that acts on the glutamate system to produce rapid antidepressant effects in adults with treatment-resistant depression and major depressive disorder with acute suicidal ideation.

That difference in mechanism matters. For people whose brains haven't responded to conventional medications, targeting the glutamate system can open a new door. Many patients report feeling a meaningful shift in their mood within hours or days, rather than the weeks it typically takes for standard antidepressants to build up in the system.

Who Is a Candidate for Esketamine in Allen, TX?

Not everyone with depression will qualify for Spravato, and that's okay. It's specifically designed for a defined group of people who have already tried other treatments without success.

According to Johns Hopkins Medicine, esketamine is approved for people with treatment-resistant depression, defined as trying at least two other antidepressants without achieving remission or at least 50% improvement, and it can provide relief within hours. If that description sounds familiar, Spravato may be worth exploring.

You may be a good candidate if:

  • You have tried two or more antidepressants at adequate doses without significant improvement
  • You have been diagnosed with major depressive disorder (MDD)
  • You are an adult (18 or older)
  • You do not have certain medical conditions that would make esketamine unsafe, such as uncontrolled hypertension or a history of psychosis
  • You are willing to have someone drive you to and from each treatment session

A thorough psychiatric evaluation is always the first step. Our team in Allen will take time to review your full history, current medications, and health background before recommending Spravato.

How Does Spravato Treatment Work?

Spravato is not a take-home medication. Because of its potential for sedation and dissociation, it is administered in a certified healthcare setting under direct medical supervision. This is an important safety requirement, not a barrier.

Here is what a typical Spravato session looks like:

  • Arrival and check-in: You arrive at our Allen clinic and a clinical staff member reviews how you're feeling that day.
  • Self-administration with supervision: Under the guidance of our team, you self-administer the nasal spray in one or both nostrils.
  • Monitoring period: You remain in our comfortable observation space for approximately two hours while we monitor your blood pressure, mood, and any side effects.
  • Safe discharge: Once you're cleared, a designated driver takes you home. You should not drive or operate heavy machinery on the day of treatment.

The treatment schedule typically begins with twice-weekly sessions for four weeks, then moves to weekly sessions, and eventually to every-other-week maintenance sessions. Your psychiatrist will adjust this schedule based on how you respond.

What Does the Research Say?

The evidence behind Spravato continues to grow. A review of 14 research papers published on PubMed Central (NIH) supports the recommendation of esketamine as an add-on to antidepressants for treatment-resistant depression, though researchers note that more data is still needed to fully understand long-term efficacy and safety.

Additional research published on PubMed Central (NIH) found that intranasal esketamine provides significant short-term symptom improvement in treatment-resistant depression and decreases suicidal risk, with transient mild-to-moderate side effects. The FDA has issued boxed warnings for sedation, dissociation, and abuse potential, which is why Spravato is only available through a certified REMS program in approved clinical settings.

Research also suggests that Spravato works across a range of patients. A post hoc analysis published in PubMed (National Library of Medicine) found that intranasal esketamine combined with an oral antidepressant was effective in patients with treatment-resistant depression regardless of baseline irritability levels, suggesting broad applicability.

What Are the Side Effects of Spravato?

It's natural to have questions about side effects, and we believe in giving you honest, complete information so you can make a confident decision.

The most commonly reported side effects during or shortly after a Spravato session include:

  • Dissociation or a feeling of being detached from your surroundings (this is temporary and monitored closely)
  • Dizziness or lightheadedness
  • Nausea
  • Sedation or drowsiness
  • Increased blood pressure during the session
  • Headache

These effects are typically mild to moderate and resolve within the two-hour monitoring window. Because you are in a supervised clinical setting throughout your session, our team is present to support you every step of the way. We never leave you to navigate this alone.

Spravato does carry a risk of abuse and misuse, which is why it is only dispensed and administered in certified healthcare settings. It is not available as a prescription to take at home.

Spravato vs. IV Ketamine: What's the Difference?

You may have heard about IV ketamine infusions as a treatment for depression and wondered how Spravato compares. Both treatments work on the glutamate system and can produce rapid antidepressant effects, but there are some key differences.

Spravato (esketamine) is FDA-approved specifically for treatment-resistant depression and major depressive disorder with acute suicidal ideation. It is covered by many insurance plans, including Medicare, when criteria are met. IV ketamine infusions, while widely used, are still considered off-label for depression and are typically not covered by insurance.

For many patients, Spravato is the more accessible and financially practical option. Our team can help you understand your specific insurance benefits and what to expect in terms of cost.

Spravato and Therapy: A Powerful Combination

One thing that sets our approach apart is that we never view Spravato as a standalone fix. Depression is complex, and lasting recovery almost always involves more than medication alone.

At our Allen location, Spravato treatment is integrated within a full continuum of care. That means you have access to individual therapy, psychiatric care and medication management, and even our Intensive Outpatient Program (IOP) if you need a higher level of support. Many of our Spravato patients also benefit from EMDR therapy or somatic therapy to address the underlying roots of their depression alongside the neurological relief that esketamine can provide.

We believe that real, lasting change is built on the therapeutic relationship. Spravato can help lift the weight of depression enough for therapy to become more effective, and therapy can help you build the skills and insight to sustain that improvement over time.

Insurance Coverage for Spravato in Allen, TX

Cost is a real concern for many people, and we want to be upfront about how coverage works. Spravato is FDA-approved, which means it is eligible for coverage under many major insurance plans when medical necessity criteria are met.

We are in-network with several major insurers, including Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, and Baylor Scott and White. Our team will work with you to verify your benefits before you begin treatment, so there are no surprises. For those without insurance coverage, we also offer private-pay options and accept CareCredit to help make treatment financially accessible.

Why Choose Our Allen, TX Spravato Clinic?

There are a few things that make our practice different from a standalone ketamine clinic or a large hospital system.

First, we offer integrated care. Therapy and psychiatry are under one roof, which means your Spravato provider and your therapist can communicate directly and coordinate your care. You don't have to manage multiple providers across different systems.

Second, we are available when you need us. Our Allen location offers in-person care seven days a week, from 8am to 8pm. We know that depression doesn't follow a Monday-through-Friday schedule, and neither do we.

Third, we lead with the therapeutic relationship. Every person who walks through our doors is treated as a whole person, not a diagnosis. Our clinicians take time to understand your story, your goals, and your concerns before recommending any treatment, including Spravato.

We also serve patients across North Texas, with locations in Denton and North Richland Hills in addition to Allen, and we offer telehealth services statewide for therapy and medication management.

Frequently Asked Questions About Spravato in Allen, TX

How long does it take for Spravato to work?

Many patients notice improvement within the first one to two weeks of treatment. Some report feeling a shift even after their first or second session. Results vary by individual, and your psychiatrist will monitor your progress closely throughout the induction phase.

Do I have to stop my current antidepressant to use Spravato?

No. Spravato is designed to be used alongside an oral antidepressant, not as a replacement. Your prescribing psychiatrist will review your current medications and make any necessary adjustments.

Is Spravato the same as recreational ketamine?

Esketamine is a derivative of ketamine, but it is a pharmaceutical-grade, FDA-approved medication administered in a controlled clinical setting at carefully calibrated doses. It is not the same as recreational ketamine use.

How do I get started?

The first step is a psychiatric evaluation with one of our providers. During this appointment, we'll review your history, discuss your goals, and determine whether Spravato is an appropriate fit for you. If it is, we'll walk you through the next steps, including insurance verification and scheduling your first session.

Take the Next Step Toward Relief

If you've been struggling with treatment-resistant depression and feel like you've run out of options, we want you to know that there is still hope. Spravato has helped many people find relief when nothing else worked, and our team in Allen is here to support you through every step of the process.

You deserve care that takes your history seriously, respects your concerns, and works alongside you toward real, lasting change. That's exactly what we're here to provide.

Ready to find out if Spravato is right for you? Contact our Allen, TX office today to schedule a psychiatric evaluation. We're available seven days a week, and we'd be honored to be part of your path forward.